Positive top-line findings announced for congenital obesity drug HealioRhythm Pharmaceuticals announced positive results from two phase 3 clinical trials evaluating setmelanotide, a melanocortin-4 receptor agonist for the …
From https://jamesjohnson10.blogspot.com/2019/08/positive-top-line-findings-announced.html
from
https://jamesjohnson10.wordpress.com/2019/08/20/positive-top-line-findings-announced-for-congenital-obesity-drug-healio/
No comments:
Post a Comment